SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-017001
Filing Date
2020-01-28
Accepted
2020-01-28 16:31:58
Documents
9
Period of Report
2020-03-19
Effectiveness Date
2020-01-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d864868ddef14a.htm DEF 14A 928032
2 GRAPHIC g864868g01r22.jpg GRAPHIC 304327
3 GRAPHIC g864868g02m66.jpg GRAPHIC 33566
4 GRAPHIC g864868g03z11.jpg GRAPHIC 99262
5 GRAPHIC g864868g08m78.jpg GRAPHIC 50524
6 GRAPHIC g864868g27e04.jpg GRAPHIC 54665
7 GRAPHIC g864868g70d20.jpg GRAPHIC 68095
8 GRAPHIC g864868page006.jpg GRAPHIC 108297
9 GRAPHIC g864868page007.jpg GRAPHIC 87881
  Complete submission text file 0001193125-20-017001.txt   2041525
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38042 | Film No.: 20554770
SIC: 2834 Pharmaceutical Preparations